• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA作为骨肉瘤潜在的预后/诊断标志物及导致耐药的因素:综述

LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.

作者信息

Hu Siwang, Han Xuebing, Liu Gang, Wang Shuangshuang

机构信息

The Orthopedic Center, Wenling First People's Hospital (The Affiliated Wenling Hospital of Wenzhou Medical University), Wenling, China.

Hunan Provincial Engineering Research Center of Applied Microbial Resources Development for Livestock and Poultry, College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China.

出版信息

Front Endocrinol (Lausanne). 2024 Jul 2;15:1415722. doi: 10.3389/fendo.2024.1415722. eCollection 2024.

DOI:10.3389/fendo.2024.1415722
PMID:39015175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11249743/
Abstract

Osteosarcoma is a common malignancy that often occurs in children, teenagers and young adults. Although the treatment strategy has improved, the results are still poor for most patients with metastatic or recurrent osteosarcomas. Therefore, it is necessary to identify new and effective prognostic biomarkers and therapeutic targets for diseases. Human genomes contain lncRNAs, transcripts with limited or insufficient capacity to encode proteins. They have been implicated in tumorigenesis, particularly regarding the onset, advancement, resistance to treatment, recurrence and remote dissemination of malignancies. Aberrant lncRNA expression in osteosarcomas has been reported by numerous researchers; lncRNAs have the potential to exhibit either oncogenic or tumor-suppressing behaviors and thus, to govern the advancement of this skeletal cancer. They are suspected to influence osteosarcoma cell growth, replication, invasion, migration, remote dissemination and programmed cell death. Additionally, they have been recognized as clinical markers, and may participate in the development of multidrug resistance. Therefore, the study of lncRNAs in the growth, metastasis, treatment and prognosis of osteosarcoma is very important for the active prevention and treatment of osteosarcoma. Consequently, this work reviews the functions of lncRNAs.

摘要

骨肉瘤是一种常见的恶性肿瘤,常发生于儿童、青少年和年轻成年人。尽管治疗策略有所改进,但对于大多数转移性或复发性骨肉瘤患者来说,治疗效果仍然不佳。因此,有必要为该疾病确定新的有效预后生物标志物和治疗靶点。人类基因组包含长链非编码RNA(lncRNA),即编码蛋白质能力有限或不足的转录本。它们与肿瘤发生有关,特别是在恶性肿瘤的发生、进展、治疗耐药性、复发和远处转移方面。许多研究人员报道了骨肉瘤中异常的lncRNA表达;lncRNA有可能表现出致癌或抑癌行为,从而控制这种骨骼癌症的进展。它们被怀疑会影响骨肉瘤细胞的生长、复制、侵袭、迁移、远处转移和程序性细胞死亡。此外,它们已被确认为临床标志物,并可能参与多药耐药性的产生。因此,研究lncRNA在骨肉瘤生长、转移、治疗和预后中的作用对于骨肉瘤的积极防治非常重要。因此,本文综述了lncRNA的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/5756419a01eb/fendo-15-1415722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/f60fbd5ef9d7/fendo-15-1415722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/6b937afd887f/fendo-15-1415722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/157e86213420/fendo-15-1415722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/5756419a01eb/fendo-15-1415722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/f60fbd5ef9d7/fendo-15-1415722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/6b937afd887f/fendo-15-1415722-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/157e86213420/fendo-15-1415722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f2a/11249743/5756419a01eb/fendo-15-1415722-g004.jpg

相似文献

1
LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.长链非编码RNA作为骨肉瘤潜在的预后/诊断标志物及导致耐药的因素:综述
Front Endocrinol (Lausanne). 2024 Jul 2;15:1415722. doi: 10.3389/fendo.2024.1415722. eCollection 2024.
2
Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.长链非编码RNA在骨肉瘤中的应用:生物标志物与治疗靶点
Cell Physiol Biochem. 2017;42(4):1407-1419. doi: 10.1159/000479205. Epub 2017 Jul 17.
3
LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.LncRNA SOX2-OT 是骨肉瘤患者的一种新型预后生物标志物,通过调节 SOX2 来调节骨肉瘤细胞的增殖和迁移。
IUBMB Life. 2017 Nov;69(11):867-876. doi: 10.1002/iub.1681. Epub 2017 Sep 29.
4
The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.长链非编码 RNA 在骨肉瘤干细胞调控中的新兴作用。
Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):966-974. doi: 10.26355/eurrev_202202_28006.
5
Long Non-Coding RNA as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma.长链非编码 RNA 作为骨肉瘤化疗敏感性和临床结局的潜在生物标志物。
Int J Mol Sci. 2021 Oct 16;22(20):11168. doi: 10.3390/ijms222011168.
6
LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway.长链非编码RNA MALAT1通过激活PI3K-Akt信号通路促进骨肉瘤的癌转移。
Cell Physiol Biochem. 2018;51(3):1313-1326. doi: 10.1159/000495550. Epub 2018 Nov 27.
7
Long non-coding RNAs in osteosarcoma.骨肉瘤中的长链非编码RNA
Oncotarget. 2017 Mar 21;8(12):20462-20475. doi: 10.18632/oncotarget.14726.
8
Cancer stem cells in osteosarcoma.骨肉瘤中的癌症干细胞。
Cancer Lett. 2017 Feb 1;386:189-195. doi: 10.1016/j.canlet.2016.11.019. Epub 2016 Nov 25.
9
LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.长链非编码 RNA LINC00628 通过调控 PI3K/Akt 信号通路抑制骨肉瘤的生长和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5857-5866. doi: 10.26355/eurrev_201809_15915.
10
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.生长停滞特异性5长链非编码RNA作为骨肉瘤化疗耐药的重要生物标志物
Anticancer Drugs. 2022 Mar 1;33(3):278-285. doi: 10.1097/CAD.0000000000001263.

引用本文的文献

1
Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma.非编码RNA在高级别中央型骨肉瘤诊断病理学中的应用
Diagnostics (Basel). 2025 May 28;15(11):1355. doi: 10.3390/diagnostics15111355.

本文引用的文献

1
Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis.长链非编码 RNA GAS5 通过 microRNA-26b-5p/TP53INP1 轴促进骨肉瘤细胞对顺铂的化疗敏感性。
J Orthop Surg Res. 2023 Nov 22;18(1):890. doi: 10.1186/s13018-023-04387-z.
2
METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.METTL3 介导的 MALAT1 m6A 修饰促进骨肉瘤细胞的增殖和转移。
Mol Biotechnol. 2024 Dec;66(12):3538-3548. doi: 10.1007/s12033-023-00953-2. Epub 2023 Oct 28.
3
The Long Non-Coding RNA ANRIL in Cancers.
癌症中的长链非编码RNA ANRIL
Cancers (Basel). 2023 Aug 17;15(16):4160. doi: 10.3390/cancers15164160.
4
Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression.长非编码 RNA TUG1 通过增强 ZBTB7C 表达促进骨肉瘤的恶性进展。
Biomed J. 2024 Jun;47(3):100651. doi: 10.1016/j.bj.2023.100651. Epub 2023 Aug 9.
5
Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1.外泌体介导的 miR-144-3p 通过调节 ZEB1 促进铁死亡抑制骨肉瘤增殖、迁移和侵袭。
Mol Cancer. 2023 Jul 17;22(1):113. doi: 10.1186/s12943-023-01804-z.
6
LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy.长链非编码RNA MEG3通过miR-21-5p/p53途径调控抗肿瘤免疫和自噬,从而促进骨肉瘤的化疗敏感性。
Genes Dis. 2021 Nov 24;10(2):531-541. doi: 10.1016/j.gendis.2021.11.004. eCollection 2023 Mar.
7
Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis.没食子酸通过H19-Wnt/β-连环蛋白调控轴介导对骨肉瘤的肿瘤抑制作用。
J Orthop Translat. 2023 Jan 4;39:34-42. doi: 10.1016/j.jot.2022.12.003. eCollection 2023 Mar.
8
Targeting lncRNA/Wnt axis by flavonoids: A promising therapeutic approach for colorectal cancer.靶向 lncRNA/Wnt 轴的黄酮类化合物:结直肠癌有前途的治疗方法。
Phytother Res. 2022 Nov;36(11):4024-4040. doi: 10.1002/ptr.7550. Epub 2022 Oct 13.
9
FER1L4: A Long Non-coding RNA with Multiple Roles in the Occurrence and Development of Tumors.FER1L4:一种在肿瘤发生和发展中具有多种作用的长非编码 RNA。
Curr Pharm Des. 2022;28(16):1334-1341. doi: 10.2174/1381612828666220324141016.
10
METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability m6A Modification.METTL3通过增加DANCR mRNA稳定性的m6A修饰促进骨肉瘤进展。
Front Cell Dev Biol. 2022 Jan 12;9:784719. doi: 10.3389/fcell.2021.784719. eCollection 2021.